ALIRT Research Reports Continued Expansion of U.S. Life Insurers' Reinsurance Activity in Bermuda

ALIRT reports U.S. life insurers ceded about $1.1T of life and annuity liabilities to Bermuda reinsurers as of year-end 2025, up from a 30.9% share of ceded reserves in 2021 to 40.7% in 2025. Between 2021-2025, Bermuda-ceded reserves more than doubled and 2025 alone saw over $73B of new Bermuda reinsurance transactions. The report cites capital-management flexibility and third-party capital access, while noting regulatory focus on reserve adequacy, liquidity testing, and scrutiny of sidecars/affiliated transactions—keeping the near-term impact more informational than market-moving.

Analysis

The investable takeaway is less about premiums and more about capital velocity: the ecosystem that packages liabilities into fee-generating assets should keep winning as long as regulators tolerate the structure. That favors public proxies tied to insurance AUM and alternative credit deployment, especially APO/Athene and, secondarily, KKR/BX where insurance-linked capital can be recycled into spread products. The hidden benefit is earnings durability: every incremental dollar of reinsured reserve tends to support more asset deployment, which lifts fee revenue and ROE without obvious top-line growth.

The risk is that this is a slow-burn regulatory trade, not a one-day event. Near term, the market will likely ignore it unless there is an NAIC, state DOI, or Bermuda-specific headline on liquidity testing, reserve adequacy, or sidecar transparency. Over 1-3 months, the first pressure point is any update from insurers with large annuity/legacy-block exposure (LNC, PRU, MET, BHF) showing slower cessions or higher capital drag; over 6-18 months, tighter look-through rules would shift volume toward more transparent reinsurers and away from opaque affiliated structures.

The contrarian miss is that the consensus views Bermuda as a permanent capital arbitrage, but in a stress scenario the same structures can become correlated liquidity trades. If private credit marks weaken while policyholder behavior and counterparties move together, the apparent capital release can reverse into a funding and RBC problem. That is why the cleanest downside is not 'Bermuda exposure' broadly, but names most dependent on aggressive capital management to sustain growth.

Key Decisions for Investors

• Long APO vs short PRU or LNC on a 3-6 month horizon: APO benefits from continued insurance-linked AUM accumulation, while the short leg captures any re-rating of capital-intensive life insurers if regulatory scrutiny tightens; target 10-15% relative outperformance, stop if statutory capital metrics stay stable through next reporting cycle.
• Use KIE as a hedge, not a primary short: if NAIC/Bermuda commentary turns hostile, a short in KIE can express the broader derating of insurance capital-arbitrage models without betting on a single private Bermuda platform.
• Accumulate RGA on weakness only if the market overreacts to Bermuda-sidecar headlines: a shift toward transparent reinsurance could improve competitive positioning, but entry should wait for a pullback tied to regulatory noise rather than a direct earnings miss.
• Set a catalyst alert around next statutory/reserve filings for LNC, PRU, MET, and BHF: if cession growth decelerates or RBC ratios compress, fade rallies in those names; if disclosures show no change, the thesis is not actionable and should be de-emphasized.